ao1c07335_si_001.pdf (326.34 kB)
Interpreting the Pharmacological Mechanisms of Sho-saiko-to on Thyroid Carcinoma through Combining Network Pharmacology and Experimental Evaluation
journal contributionposted on 2022-03-25, 04:29 authored by Kun Wang, Ruijie Qian, Hongyan Li, Chenyang Wang, Ying Ding, Zairong Gao
Sho-saiko-to is a well-known traditional Chinese medicine compound and is considered to have therapeutic effects against many diseases, including thyroid cancer (TC). However, the mechanisms and therapeutic targets of Sho-saiko-to against TC remain unclear. In this study, network pharmacology, molecular docking, and cell experiments were combined to predict and verify the targets and mechanisms of the active ingredients of Sho-saiko-to against TC. The results demonstrated that the main chemical ingredients of Sho-saiko-to could suppress the viability and proliferation of TC cells, promote apoptosis through the caspase3 pathway, and induce autophagy through the PI3K-AKT pathway. In addition, Sho-saiko-to could also induce the redifferentiation of anaplastic thyroid cancer. Our study provides a novel approach for treating differentiated thyroid cancer (DTC) or radioactive iodine refractory differentiated thyroid cancer (RAIR-DTC).
including thyroid canceranaplastic thyroid cancermain chemical ingredientstc remain unclearexperimental evaluation shocould also inducecombining network pharmacologynetwork pharmacologythyroid carcinomainduce autophagycould suppressactive ingredientstherapeutic effectstc cellstc ).results demonstratedpromote apoptosisnovel approachmolecular dockingmany diseasescell experimentscaspase3 pathwayakt pathway